Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy

Peter G. J. ter Horst, Karin H. M. Larmené‐Beld, Judith Bosman, Elly L. van der Veen, André Wieringa, J. P. Smit

Journal of Clinical Pharmacy and Therapeutics · 2014 · 14 citations · 8 references

Abstract

Venlafaxine concentrations decreases during pregnancy, and the ratio of the concentrations of O-desmethylvenlafaxine/venlafaxine increases during pregnancy. Pregnant women using venlafaxine are at risk for subtherapeutic concentrations, therefore routine monitoring of concentrations venlafaxine and O-desmethylvenlafaxine is recommendable during pregnancy.

References

8